Healthcare provider profile · identity verified

James K. Redula, MD

Family Practice · MODESTO, CA · NPI 1295813194

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	447	166
Lisinopril	Lisinopril	349	128
Atenolol	Atenolol	273	91
Amlodipine Besylate	Amlodipine Besylate	272	109
Levothyroxine Sodium	Levothyroxine Sodium	241	86
Losartan Potassium	Losartan Potassium	221	85
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	185	63
Hydrochlorothiazide	Hydrochlorothiazide	178	69
Tamsulosin Hcl	Tamsulosin Hcl	176	63
Omeprazole	Omeprazole	167	54
Fluticasone Propionate	Fluticasone Propionate	163	67
Trazodone Hcl	Trazodone Hcl	134	36
Albuterol Sulfate Hfa	Albuterol Sulfate	131	67
Famotidine	Famotidine	130	45
Metformin Hcl	Metformin Hcl	127	48
Ibuprofen	Ibuprofen	119	47
Prednisone	Prednisone	109	64
Doxycycline Monohydrate	Doxycycline Monohydrate	108	53
Finasteride	Finasteride	108	33
Alendronate Sodium	Alendronate Sodium	105	44
Hydralazine Hcl	Hydralazine Hcl	105	34
Furosemide	Furosemide	100	42
Gabapentin	Gabapentin	99	36
Simvastatin	Simvastatin	96	34
Pantoprazole Sodium	Pantoprazole Sodium	93	37
Glipizide	Glipizide	92	32
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	92	18
Nortriptyline Hcl	Nortriptyline Hcl	88	21
Ozempic	Semaglutide	87	14
Metoprolol Tartrate	Metoprolol Tartrate	82	34
Alprazolam	Alprazolam	81	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	80	30
Lovastatin	Lovastatin	78	26
Zolpidem Tartrate	Zolpidem Tartrate	73	12
Metformin Hcl Er	Metformin Hcl	70	28
Terazosin Hcl	Terazosin Hcl	70	25
Azithromycin	Azithromycin	67	57
Montelukast Sodium	Montelukast Sodium	63	25
Alvesco	Ciclesonide	62	29
Tramadol Hcl	Tramadol Hcl	59	22
Triamcinolone Acetonide	Triamcinolone Acetonide	53	33
Allopurinol	Allopurinol	49	19
Baclofen	Baclofen	46	22
Humulin N	Insulin Nph Human Isophane	46	21
Ondansetron Odt	Ondansetron	46	11
Potassium Chloride	Potassium Chloride	46	19
Propranolol Hcl	Propranolol Hcl	46	13
Duloxetine Hcl	Duloxetine Hcl	44	12
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	42	16
Lorazepam	Lorazepam	40	14
Fluconazole	Fluconazole	38	23
Pravastatin Sodium	Pravastatin Sodium	38	14
Temazepam	Temazepam	38	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	37	14
Jardiance	Empagliflozin	37	16
Metoprolol Succinate	Metoprolol Succinate	36	17
Venlafaxine Hcl Er	Venlafaxine Hcl	36	14
Cephalexin	Cephalexin	35	27
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	27
Chlorthalidone	Chlorthalidone	32	14
Pradaxa	Dabigatran Etexilate Mesylate	32	16
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	32	suppressed
Clopidogrel	Clopidogrel Bisulfate	31	11
Warfarin Sodium	Warfarin Sodium	30	suppressed
Clobetasol Propionate	Clobetasol Propionate	29	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	16
Azelastine Hcl	Azelastine Hcl	28	11
Spironolactone	Spironolactone	27	12
Hydrocortisone	Hydrocortisone	26	17
Acetaminophen-Codeine	Acetaminophen With Codeine	25	12
Tizanidine Hcl	Tizanidine Hcl	25	14
Wixela Inhub	Fluticasone Propion/Salmeterol	25	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	24	24
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	20
Colchicine	Colchicine	24	suppressed
Meloxicam	Meloxicam	24	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	24	11
Donepezil Hcl	Donepezil Hcl	23	suppressed
Humulin R	Insulin Regular, Human	22	suppressed
Glipizide Er	Glipizide	21	suppressed
Nabumetone	Nabumetone	21	13
Nystatin	Nystatin	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	11
Acyclovir	Acyclovir	19	11
Amoxicillin	Amoxicillin	19	13
Clonidine Hcl	Clonidine Hcl	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Retin-A	Tretinoin	18	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	18	suppressed
Carvedilol	Carvedilol	17	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	17	suppressed
Diazepam	Diazepam	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	12
Metronidazole	Metronidazole	16	13
Cartia Xt	Diltiazem Hcl	15	11
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Sertraline Hcl	Sertraline Hcl	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Trospium Chloride	Trospium Chloride	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	12	suppressed
Naproxen	Naproxen	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Alclometasone Dipropionate	Alclometasone Dipropionate	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error